Brain-derived pTau217 shows promise as a more accurate blood biomarker for Alzheimer's pathology

news-medical.net

A new blood biomarker, brain-derived pTau217, may detect Alzheimer's pathology more accurately than existing tests. Researchers found this brain-derived version showed stronger diagnostic performance and was less affected by kidney dysfunction, suggesting improved specificity for Alzheimer's disease. This development could lead to more reliable and accessible blood tests for diagnosing Alzheimer's, a condition affecting millions globally.


With a significance score of 4.3, this news ranks in the top 3.1% of today's 26273 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Brain-derived pTau217 shows promise as a more accurate blood biomarker for Alzheimer's pathology | News Minimalist